Transcatheter aortic valve implantation for combined aortic and mitral stenoses: Insights from the OCEAN-TAVI Registry.
Nahoko KatoMinoru TabataMasahiko NoguchiJoji ItoKotaro ObunaiHiroyuki WatanabeFumiaki YashimaShinichi ShiraiNorio TadaToru NaganumaMasahiro YamawakiFutoshi YamanakaHiroshi UenoYohei OhnoMasaki IzumoHidetaka NishinaMasahiko AsamiYusuke WatanabeMasanori YamamotoToshiaki OtsukaKentaro Hayashidanull nullPublished in: ESC heart failure (2024)
In patients undergoing TAVI for severe AS, those with moderate or severe MS experienced worse outcomes after TAVI compared with those without MS. Patients with combined AS and MS sustained symptom improvement at 1-year post-TAVI. MAC severity was a useful predictor of adverse events compared with MS haemodynamics such as TMG and MVA in patients with combined AS and MS.
Keyphrases
- transcatheter aortic valve implantation
- aortic valve
- aortic stenosis
- mass spectrometry
- aortic valve replacement
- multiple sclerosis
- ms ms
- transcatheter aortic valve replacement
- patients undergoing
- left ventricular
- ejection fraction
- early onset
- mitral valve
- heart failure
- pulmonary artery
- pulmonary arterial hypertension